Devices for the ‘connected patient’

New wireless technology from Cambridge Consultants connects patients via monitoring or treatment devices, such as inhalers, to healthcare providers. The 'connected patient' technology improves...

NICE looks to future innovation

The National Institute for Clinical Excellence (NICE) will improve its uptake of medical technologies, according to chairman Professor Sir Michael Rawlins. NICE has...

Further treatment use for Aclasta

Once-yearly Aclasta (zoledronic acid 5 mg) has been approved in the European Union to treat men and postmenopausal women with osteoporosis caused by long-term...

CHMP approves orphan product

The Committee for Medicinal Products for Human Use (CHMP) has recommended a conditional EU marketing authorisation for Gilead’s orphan medicinal product Cayston. The...

Ceuta backs school of enterprise

Ceuta Healthcare, an outsourcing company in the health and beauty industry, is backing a training initiative by Dragon’s Den entrepreneur Peter Jones. The...

No appeal against Alzheimer’s decision

Eisai and Pfizer have decided not to appeal NICE’s decision on Alzheimer’s drugs and have called for an expedited review of guidance for the...

EMEA launches new transparency policy

The European Medicines Agency has described its vision on openness towards stakeholders in a new draft transparency policy. Since its inauguration in 1995,...

Fruitful summer for pharma expected

Experts are predicting a boost to European pharmaceutical and biotech market revenue later this summer, following an important decision from the Enlarged Board of...

Sanofi-Aventis pledges flu vaccines

Sanofi-Aventis will donate 100 million doses of influenza vaccine to the World Health Organization (WHO) to help people in developing countries, the company has...

Innovation fund for life sciences

The life sciences industry has welcomed Lord Mandelson’s announcement of the creation of an Innovation Fund which will be corner-stoned by Government with investment...

Latest articles

The Royal Society for Public Health (RSPH) has welcomed the publication of the highly anticipated Government's Prevention Green Paper.

RSPH sets out detail of Government Prevention Green Paper

The Royal Society for Public Health (RSPH) has welcomed the publication of the highly anticipated Government's Prevention Green Paper. The document sets out the...
The Cabinet Office and Department of Health and Social Care have published their Prevention Green Paper, Advancing our health: prevention in the 2020s. It sets out plans to tackle the causes of preventable ill health in England.

Prevention Green Paper published – Advancing our health: prevention in the 2020s

The Cabinet Office and Department of Health and Social Care have published their Prevention Green Paper, Advancing our health: prevention in the 2020s. It...
Sanofi has signed a strategic deal for Tamiflu in the US. The agreement with Roche is for the exclusive over-the-counter (OTC) rights to Tamiflu®

Sanofi signs strategic deal for Tamiflu® in the US

Sanofi has signed a strategic deal for Tamiflu in the US. The agreement with Roche is for the exclusive over-the-counter (OTC) rights to Tamiflu®...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Sanofi has signed a strategic deal for Tamiflu in the US. The agreement with Roche is for the exclusive over-the-counter (OTC) rights to Tamiflu®

Sanofi signs strategic deal for Tamiflu® in the US

Sanofi has signed a strategic deal for Tamiflu in the US. The agreement with Roche is for the exclusive over-the-counter (OTC) rights to Tamiflu®...

Embedding patient centric care with digital health apps

Health professionals see apps as a crucial step on the road to care that is more efficient and more patient centred than today. How...

How can the NHS deliver patient centric care?

‘Patient centricity’, the process of designing a service or solution around a patient’s wants, needs and preferences, is a key aspiration for the NHS....
Advanced renal cell carcinoma treatment receives EAMS positive scientific opinion

Advanced renal cell carcinoma treatment receives EAMS positive scientific opinion

Advanced renal cell carcinoma treatment receives Early Access to Medicines Scheme (EAMS) positive scientific opinion from the UK Medicines and Healthcare Products Regulatory Agency...